Dr. Lal Pathlabs Ltd.

NSE: LALPATHLAB | BSE: 539524 | ISIN: INE600L01024 | Industry: Healthcare Services
| Expensive Rocket
1909.0000 -7.70 (-0.40%)
NSE Sep 11, 2026 15:31 PM
Volume: 224.9K
 

1909.00
-0.40%
Emkay
DLPL delivered a strong Q4FY26 print, with revenue growing 17% YoY majorly on the back of volume growth (sample/patient: 13%/8%).
Dr. Lal Pathlabs Ltd. has an average target of 1662.75 from 4 brokers.
More from Dr. Lal Pathlabs Ltd.
All Rapid Results
Recommended